Przejdź do zawartości
Merck

An elderly patient with chronic hyponatremia.

Clinical journal of the American Society of Nephrology : CJASN (2012-10-06)
Tomas Berl
ABSTRAKT

Hyponatremia is the most common electrolyte disorder. With the aging of the population and the greater propensity of the elderly to develop hyponatremia, this electrolyte disorder is of increasing importance to the practicing nephrologist. In this Attending Rounds, an illustrative patient with hyponatremia is presented. The reasons for the increased incidence and prevalence of hyponatremia in the elderly are discussed, with emphasis on the effects of aging on urinary dilution, the frequently multifactorial nature of hyponatremia in this population, and the absence of a definite cause for inappropriate and persistent vasopressin release in many such patients. The rationale for treating the hyponatremia, even when apparently asymptomatic, is discussed, with attention to cognitive function, gait, and bone structure disturbances that increase the risk for fractures. The various available treatment approaches, including water restriction, demeclocycline, loop diuretics with NaCl supplementation, urea, and vasopressin antagonists are summarized, with emphasis on the efficacy and limitations of each of these therapies.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Supelco
Demeclocycline hydrochloride hydrate, VETRANAL®, analytical standard
Sigma-Aldrich
Demeclocycline hydrochloride, powder or crystals